164
Participants
Start Date
October 13, 2020
Primary Completion Date
September 6, 2022
Study Completion Date
October 6, 2025
Pevonedistat
Pevonedistat IV infusion.
Venetoclax
Venetoclax tablets.
Azacitidine
Azacitidine IV or SC injection.
Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano
Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Turin
Northwell Health Cancer Institute, Lake Success
Stony Brook Medicine, Stony Brook
Institut dHematologie de Basse Normandie, Caen
Istituto Clinico Humanitas, Rozzano
ASST di Monza - Azienda Ospedaliera San Gerardo, Monza
University of Virginia Health System, Charlottesville
West Virginia University Hospital, Morgantown
Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia
EDOG - Institut Claudius Regaud - PPDS, Toulouse
AdventHealth (Florida Hospital) - Transplant Institute, Orlando
University of Miami Miller School of Medicine, Miami
CHU de Grenoble, Grenoble
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna
Norton Cancer Institute - Suburban, Louisville
CHRU Nantes, Nantes
University Hospitals Cleveland Medical Center, Cleveland
Azienda Ospedaliera Universitaria Careggi, Florence
Medical College of Wisconsin, Milwaukee
Avera Cancer Institute, Sioux Falls
CHRU Lille, Lille
HCA Midwest Health - SCRI - PPDS, Kansas City
Centre Hospitalier Lyon Sud, Pierre-Bénite
Tulane Medical Center, New Orleans
Centre Hospitalier Le Mans, Le Mans
The University of Oklahoma Health Sciences Center, Oklahoma City
Hopital Saint Antoine, Paris
Hopital Saint Louis, Paris
Houston Methodist Cancer Center, Houston
Joe Arrington Cancer Research and Treatment Center, Lubbock
Intermountain LDS Hospital, Salt Lake City
Banner MD Anderson Cancer Center, Gilbert
CHRU de Poitiers La Miletrie, Poitiers
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria
UC San Diego Moores Cancer Center, La Jolla
UC Irvine Medical Center, Orange
Hopital Avicenne, Bobigny
Massachusetts General Hospital, Boston
Icahn School of Medicine at Mount Sinai, New York
University of North Carolina at Chapel Hill, Chapel Hill
Rhode Island Hospital, Providence
University of Alberta, Edmonton
Tom Baker Cancer Centre, Tom Baker Cancer Centre
London Health Sciences Centre, London
Ottawa Hospital, Ottawa
Hopital de L'enfant Jesus, Québec
CHU de Nice, Nice
Ospedale Santa Maria Della Misericordia Di Perugia, Perugia
Szpital Uniwersytecki w Krakowie, Krakow
MTZ Clinical Research Sp z o o, Warsaw
Instytut Hematologii i Transfuzjologii, Warsaw
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok
Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy, Bydgoszcz
Uniwersyteckie Centrum Kliniczne, Gdansk
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Lodz
Lead Sponsor
Takeda
INDUSTRY